BlossomHill Therapeutics, Inc.
- BLSM
- NASDAQ
- Biotechnology
- Oncology Small Molecules
- Cancer Therapeutics
$14.16
Today +1.58%Quote Oct 19, 2026, 08:00 PM UTC
−44.99%over the last month
Max drawdown −48.0%From 1-month high −47.2%3 months −11.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About BlossomHill Therapeutics
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
69
Market value
$411.8M
Quote Oct 19
Floor
$12.09
14.6% below price
Resistance
$15.16
7.0% above price
Price vs analyst targets
2 analysts
Lowest target
$35.00Highest target
$40.00
$35.00Highest target
$40.00
- Price $14.16
- Average target $38.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 171% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BLSMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free